Salivary Glands and Periodontal Changes in a Population of Sjögren's and Sicca Syndrome Treated by Pilocarpine: A Pilot Study

[1]  A. Iagnocco,et al.  Video clip assessment of a salivary gland ultrasound scoring system in Sjögren’s syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise , 2019, Annals of the rheumatic diseases.

[2]  M. Cifuentes,et al.  Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double‐blind randomized controlled trial , 2018, The British journal of dermatology.

[3]  J. Choe,et al.  Salivary gland ultrasonography findings are associated with clinical, histological, and serologic features of Sjögren’s syndrome , 2018, Scandinavian journal of rheumatology.

[4]  R. Moots,et al.  Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy , 2017, Annals of the rheumatic diseases.

[5]  B. Cochener,et al.  Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome , 2017, Arthritis Research & Therapy.

[6]  A. Saraux,et al.  Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren's syndrome. , 2016, Joint, bone, spine : revue du rhumatisme.

[7]  B. Cochener,et al.  A prospective evaluation of dental and periodontal status in patients with suspected Sjögren's syndrome. , 2016, Joint, bone, spine : revue du rhumatisme.

[8]  Shuntaro Sato,et al.  Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome. , 2016, Rheumatology.

[9]  J. Pers,et al.  Treatment of primary Sjögren syndrome , 2012, Nature Reviews Rheumatology.

[10]  D. Caramella,et al.  Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases. , 2015, Rheumatology.

[11]  R. Shibata,et al.  Efficacy and safety of pilocarpine mouthwash in elderly patients with xerostomia. , 2015, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[12]  J. Baker,et al.  Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome. , 2014, Clinical and experimental rheumatology.

[13]  F. Salaffi,et al.  Ultrasonography of the salivary glands: the role of grey-scale and colour/power Doppler. , 2014, Clinical and experimental rheumatology.

[14]  J. Yepes,et al.  Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study. , 2013, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[15]  B. Cochener,et al.  Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria? , 2013, Arthritis and rheumatism.

[16]  K. Ohtomo,et al.  Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese. , 2009, Auris, nasus, larynx.

[17]  L. Berk.  Systemic pilocarpine for treatment of xerostomia , 2008 .

[18]  J. Pers,et al.  Anti–TNF‐α Immunotherapy Is Associated With Increased Gingival Inflammation Without Clinical Attachment Loss in Subjects With Rheumatoid Arthritis , 2008 .

[19]  J. Pers,et al.  Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. , 2008, Journal of periodontology.

[20]  B. Cochener,et al.  Ultrasound assessment of salivary glands in patients with primary Sjögren’s syndrome treated with rituximab: Quantitative and Doppler waveform analysis , 2007, Biologics : targets & therapy.

[21]  A. Vissink,et al.  Progression of salivary gland dysfunction in patients with Sjögren’s syndrome , 2006, Annals of the rheumatic diseases.

[22]  Cheng-Han Wu,et al.  Pilocarpine Hydrochloride for the Treatment of Xerostomia in Patients with Sjögren's Syndrome in Taiwan—A Double-blind, Placebo-controlled Trial , 2006, Journal of the Formosan Medical Association.

[23]  M. Greenberg,et al.  Pilocarpine toxicity and the treatment of xerostomia. , 2004, The Journal of emergency medicine.

[24]  H. M. Barros,et al.  Effect of pilocarpine mouthwash on salivary flow. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[25]  P. Petersen,et al.  Dental caries and dental health behavior of patients with primary Sjo¨gren syndrome , 2001 .

[26]  F. Salaffi,et al.  Ultrasonography and Colour Doppler Sonography of Salivary Glands in Primary Sjo¨gren’s Syndrome , 2001, Clinical Rheumatology.

[27]  K. Eguchi,et al.  Abnormal blood flow to the submandibular glands of patients with Sjögren's syndrome: Doppler waveform analysis. , 2000, The Journal of rheumatology.

[28]  F. Vivino,et al.  Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. , 1999, Archives of internal medicine.

[29]  L. Solbiati,et al.  Color Doppler Sonography of Salivary Glands , 1994, AJR. American journal of roentgenology.

[30]  G. Rossi,et al.  Salivary gland echography in primary and secondary Sjögren's syndrome. , 1992, Clinical and experimental rheumatology.

[31]  N. Ross,et al.  A modified gingival index for use in clinical trials. , 1986, Clinical preventive dentistry.

[32]  T. Wheeler,et al.  Side Effects and Ways to Avoid Them , 1982 .

[33]  T. Wheeler,et al.  Miotics: side effects and ways to avoid them. , 1982, Ophthalmology.

[34]  J. Nikolić,et al.  Duration of improvement of rheumatoid arthritis after good response to cyclophosphamide treatment. , 1978, Scandinavian journal of rheumatology.

[35]  S P Ramfjord,et al.  The Periodontal Disease Index (PDI). , 1967, Journal of periodontology.

[36]  H. Löe,et al.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. , 1964, Acta odontologica Scandinavica.